Astera Labs, Inc. (NASDAQ:ALAB) Short Interest Up 12.8% in September
by Michael Walen · The Markets DailyAstera Labs, Inc. (NASDAQ:ALAB – Get Free Report) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 11,100,000 shares, an increase of 12.8% from the September 15th total of 9,840,000 shares. Based on an average daily volume of 3,010,000 shares, the days-to-cover ratio is presently 3.7 days. Currently, 9.8% of the company’s shares are sold short.
Analyst Ratings Changes
A number of research analysts recently weighed in on ALAB shares. Deutsche Bank Aktiengesellschaft reduced their target price on Astera Labs from $85.00 to $60.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. JPMorgan Chase & Co. decreased their target price on Astera Labs from $95.00 to $70.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. Stifel Nicolaus cut their price target on shares of Astera Labs from $87.00 to $80.00 and set a “buy” rating on the stock in a report on Monday, August 5th. Needham & Company LLC reaffirmed a “buy” rating and set a $65.00 price target on shares of Astera Labs in a research report on Wednesday, October 9th. Finally, Craig Hallum dropped their price objective on shares of Astera Labs from $90.00 to $75.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Eleven research analysts have rated the stock with a buy rating, According to data from MarketBeat, Astera Labs currently has a consensus rating of “Buy” and an average target price of $73.09.
Read Our Latest Stock Analysis on ALAB
Astera Labs Trading Down 3.8 %
ALAB opened at $62.47 on Wednesday. The firm’s 50 day moving average is $46.67 and its 200-day moving average is $58.06. Astera Labs has a 52-week low of $36.22 and a 52-week high of $95.21.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.02. The firm had revenue of $76.90 million for the quarter, compared to analysts’ expectations of $72.41 million. The firm’s revenue for the quarter was up 17.8% on a year-over-year basis. On average, sell-side analysts anticipate that Astera Labs will post -0.54 EPS for the current year.
Insiders Place Their Bets
In related news, General Counsel Philip Mazzara sold 42,090 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $40.43, for a total value of $1,701,698.70. Following the completion of the transaction, the general counsel now directly owns 333,474 shares in the company, valued at approximately $13,482,353.82. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Astera Labs news, insider Sanjay Gajendra sold 110,000 shares of the stock in a transaction that occurred on Friday, October 11th. The shares were sold at an average price of $69.47, for a total transaction of $7,641,700.00. Following the transaction, the insider now owns 835,000 shares of the company’s stock, valued at $58,007,450. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, General Counsel Philip Mazzara sold 42,090 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $40.43, for a total transaction of $1,701,698.70. Following the sale, the general counsel now directly owns 333,474 shares of the company’s stock, valued at $13,482,353.82. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 564,458 shares of company stock valued at $31,970,841 in the last quarter.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of ALAB. Vanguard Group Inc. acquired a new stake in Astera Labs during the 1st quarter valued at approximately $127,268,000. Capital World Investors acquired a new stake in shares of Astera Labs during the first quarter worth approximately $44,514,000. Price T Rowe Associates Inc. MD bought a new stake in shares of Astera Labs in the first quarter worth $44,514,000. Bamco Inc. NY bought a new stake in shares of Astera Labs in the first quarter worth $37,095,000. Finally, Lord Abbett & CO. LLC acquired a new stake in Astera Labs in the first quarter valued at $33,141,000.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Recommended Stories
- Five stocks we like better than Astera Labs
- Dividend Payout Ratio Calculator
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- What is Insider Trading? What You Can Learn from Insider Trading
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets